Get the Stockscreener App
15.08
3.05%
-0.475
Brainsway Ltd Adr stock is traded at $15.08, with a volume of 53,031.
It is down -3.05% in the last 24 hours and down -5.34% over the past month.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
See More
Previous Close:
$15.55
Open:
$15.64
24h Volume:
53,031
Relative Volume:
0.82
Market Cap:
$285.25M
Revenue:
$38.63M
Net Income/Loss:
$1.50M
P/E Ratio:
159.92
EPS:
0.0943
Net Cash Flow:
$5.97M
1W Performance:
-1.50%
1M Performance:
-5.34%
6M Performance:
+78.88%
1Y Performance:
+60.26%
1-Day Range:
$14.73
$15.64
1-Week Range:
$14.60
$16.28
52-Week Range:
$7.84
$17.00
Brainsway Ltd Adr Stock (BWAY) Company Profile
Compare BWAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
15.08 | 295.60M | 38.63M | 1.50M | 5.97M | 0.0943 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-16-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-03-22 | Initiated | Loop Capital | Buy |
| Jul-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-20-21 | Initiated | Northland Capital | Outperform |
| May-13-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-13-19 | Initiated | Ladenburg Thalmann | Buy |
| May-13-19 | Initiated | Oppenheimer | Outperform |
| May-13-19 | Initiated | Raymond James | Outperform |
View All
Brainsway Ltd Adr Stock (BWAY) Latest News
Brainsway (NASDAQ:BWAY) Shares Up 1.9%Here's What Happened - MarketBeat
Do Options Traders Know Something About Brainsway Stock We Don't? - sharewise.com
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Increase in Short Interest - MarketBeat
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care - sharewise.com
Insider Trading At ESS Tech Inc (NYSE: GWH): What Did We Note? - stocksregister.com
Why Buying The Brainsway Ltd ADR (NASDAQ: BWAY) Stock Today Might Make Sense - stocksregister.com
Is Robo.ai Inc (NASDAQ: AIIO) Stock Good For Medium-Term Investing? - stocksregister.com
Acadian Asset Management LLC Decreases Holdings in Brainsway Ltd. Sponsored ADR $BWAY - Defense World
Brainsway stock surges after FDA clears accelerated depression treatment - Investing.com
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Declines By 20.1% - MarketBeat
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Up 191.8% in August - Defense World
Trexquant Investment LP Takes $129,000 Position in Brainsway Ltd. Sponsored ADR $BWAY - Defense World
Brainsway Ltd. Sponsored ADR $BWAY Shares Sold by DAFNA Capital Management LLC - MarketBeat
Brainsway’s (BWAY) Buy Rating Reaffirmed at HC Wainwright - Defense World
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care - sharewise.com
Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay - Barchart.com
BrainsWay invests in Neurolief ahead of depression device launch By Investing.com - Investing.com
BrainsWay invests $2.3 million in Axis mental health services provider By Investing.com - Investing.com
Are Medical Stocks Lagging Biotricity (BTCY) This Year? - NewsBreak: Local News & Alerts
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? - ca.finance.yahoo.com
Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock - NewsBreak: Local News & Alerts
Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet - Yahoo Finance
Northland Capmk Predicts Stronger Earnings for Brainsway - Defense World
Research Analysts Set Expectations for Brainsway Q3 Earnings - Defense World
What is HC Wainwright’s Estimate for Brainsway Q3 Earnings? - Defense World
Brainsway (NASDAQ:BWAY) Price Target Raised to $19.00 at Northland Securities - Defense World
Brainsway (BWAY) Projected to Post Quarterly Earnings on Wednesday - Defense World
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns - The Globe and Mail
Here's What Could Help Brainsway (BWAY) Maintain Its Recent Price Strength - Yahoo Finance
Is the Options Market Predicting a Spike in Brainsway Stock? - Yahoo Finance
GAMMA Investing LLC Acquires 8,216 Shares of Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) - Defense World
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 30.98%: Here's is How to Trade - Zacks Investment Research
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
BrainsWay reports promising results for accelerated depression treatment - Investing.com
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego - GlobeNewswire Inc.
Does Brainsway (BWAY) Have the Potential to Rally 43.88% as Wall Street Analysts Expect? - MSN
BrainsWay invests $5 million in Stella Mental Health By Investing.com - Investing.com
Earnings Estimates Moving Higher for Brainsway (BWAY): Time to Buy? - Yahoo Finance
Wall Street Analysts See a 41.31% Upside in Brainsway (BWAY): Can the Stock Really Move This High? - MSN
Brainsway Ltd Adr Stock (BWAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):